Ironwood Pharmaceuticals (IRWD) Receivables - Other (2010 - 2020)

Ironwood Pharmaceuticals has disclosed Receivables - Other across 11 years of filings, most recently posting $73.4 million for Q1 2020.

• In Q1 2020, Receivables - Other rose 5.88% year-over-year to $73.4 million; the TTM figure through Mar 2020 stood at $73.4 million (up 5.88% YoY), while the FY2019 annual figure was $106.0 million, up 76.61% from the prior year.
• Receivables - Other came in at $73.4 million for Q1 2020 at Ironwood Pharmaceuticals, down from $106.0 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $106.0 million in Q4 2019 to a low of $50.0 million in Q1 2017.
• Average Receivables - Other over 5 years is $68.3 million, with a median of $65.7 million recorded in 2018.
• Year-over-year, Receivables - Other jumped 99.62% in 2016 and declined 27.18% in 2018.
• Over 5 years, Receivables - Other stood at $63.9 million in 2016, then climbed by 23.63% to $79.0 million in 2017, then retreated by 24.05% to $60.0 million in 2018, then soared by 76.61% to $106.0 million in 2019, then tumbled by 30.73% to $73.4 million in 2020.
• Per Business Quant data, the three most recent Receivables - Other figures were $73.4 million in Q1 2020, $106.0 million in Q4 2019, and $94.6 million in Q3 2019.